D. Boral Capital Initiates Coverage On Compass Therapeutics With Buy Rating, Announces Price Target of $32
D. Boral Capital Initiates Coverage On Compass Therapeutics With Buy Rating, Announces Price Target of $32
D. Boral Capital對Compass Therapeutics發起覆蓋，評級爲買入，目標價爲32美元
D. Boral Capital analyst Jason Kolbert initiates coverage on Compass Therapeutics (NASDAQ:CMPX) with a Buy rating and announces Price Target of $32.
D. Boral Capital 分析師Jason Kolbert對Compass Therapeutics（納斯達克：CMPX）發起了覆蓋，並給予買入評級，同時宣佈目標價爲32美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間